Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-11-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
NCT05835843
Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity Index
NCT06579976
A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis
NCT00540618
Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)
NCT00749398
Golimumab Plus UVB-311nm in Psoriasis
NCT01088698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bodystudio ATBM
The PASI of the patients will be evaluated by two dermatologists then by the bodystudio ATBMs.
Bodystudio ATBM (Automatic Total Body Mapping)
The mapping of the entire body is automatically done using a high-resolution apparatus (20 photographs of the patient in 8 positions (face, back, lateral left and right, specific extremities) The photographs will be done with a standardized procedure established by FotoFinder. Every lesion is completely evaluated and the PASI score can be calculated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bodystudio ATBM (Automatic Total Body Mapping)
The mapping of the entire body is automatically done using a high-resolution apparatus (20 photographs of the patient in 8 positions (face, back, lateral left and right, specific extremities) The photographs will be done with a standardized procedure established by FotoFinder. Every lesion is completely evaluated and the PASI score can be calculated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is affiliated to a National Health System at screening visit
* Understand and sign an Informed Consent Form (ICF) at screening, prior to any investigational procedures being performed.
* Patient with moderate to severe Plaque psoriasis.
* The patient is willing and able to be evaluated by the Bodystudio ATBM: 3 minutes for a young patient and until 7 minutes for an oldest.
* The patient is able to staying up during all the total body mapping procedure
Exclusion Criteria
* Pregnant woman or who are breast-feeding
* Patient with tattoos that could influence the PASI assessment.
* Patient with skin type (phototype) V or IV according to Fitzpatrick classification
* Male patients with exceeding facial or skin hair that could influence the automatic PASI assessment.
* Patients with exceeding varicose veins.
* Patients with sun burn
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Fotofinder
UNKNOWN
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-AOI-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.